| 000 | 01501 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516215535.0 | ||
| 264 | 0 | _c20150909 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.02830-14 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNayak, S U | |
| 245 | 0 | 0 |
_aSafety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cSep 2014 |
||
| 300 |
_a5047-53 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGriffiss, J M | |
| 700 | 1 | _aMcKenzie, R | |
| 700 | 1 | _aFuchs, E J | |
| 700 | 1 | _aJurao, R A | |
| 700 | 1 | _aAn, A T | |
| 700 | 1 | _aAhene, A | |
| 700 | 1 | _aTomic, M | |
| 700 | 1 | _aHendrix, C W | |
| 700 | 1 | _aZenilman, J M | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 58 _gno. 9 _gp. 5047-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.02830-14 _zAvailable from publisher's website |
| 999 |
_c23903490 _d23903490 |
||